EPHB2 and Hepatic fibrosis: In conclusion, we demonstrate that EphB2 undergoes sulfenylation during liver fibrosis progression, which enhances its kinase activity, antagonizes its ubiquitination-mediated degradation, promotes its interactions with other proteins, and activates the downstream FAK/MAPK signaling.